HTG Molecular Diagnostics (HTGM) Misses Q1 EPS by 193c

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q1 EPS of ($2.28), $1.93 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.03 million versus the consensus estimate of $3.5 million.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c